BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32017842)

  • 1. Functional Analyses of HNF1A-MODY Variants Refine the Interpretation of Identified Sequence Variants.
    Malikova J; Kaci A; Dusatkova P; Aukrust I; Torsvik J; Vesela K; Kankova PD; Njølstad PR; Pruhova S; Bjørkhaug L
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32017842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical application of ACMG-AMP guidelines in HNF1A and GCK variants in a cohort of MODY families.
    Santana LS; Caetano LA; Costa-Riquetto AD; Quedas EPS; Nery M; Collett-Solberg P; Boguszewski MCS; Vendramini MF; Crisostomo LG; Floh FO; Zarabia ZI; Kohara SK; Guastapaglia L; Passone CGB; Sewaybricker LE; Jorge AAL; Teles MG
    Clin Genet; 2017 Oct; 92(4):388-396. PubMed ID: 28170077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of HNF1A variants in paediatric diabetes in Norway using functional and clinical investigations to unmask phenotype and monogenic diabetes.
    Svalastoga P; Kaci A; Molnes J; Solheim MH; Johansson BB; Krogvold L; Skrivarhaug T; Valen E; Johansson S; Molven A; Sagen JV; Søfteland E; Bjørkhaug L; Tjora E; Aukrust I; Njølstad PR
    Diabetologia; 2023 Dec; 66(12):2226-2237. PubMed ID: 37798422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unsupervised Clustering of Missense Variants in HNF1A Using Multidimensional Functional Data Aids Clinical Interpretation.
    Althari S; Najmi LA; Bennett AJ; Aukrust I; Rundle JK; Colclough K; Molnes J; Kaci A; Nawaz S; van der Lugt T; Hassanali N; Mahajan A; Molven A; Ellard S; McCarthy MI; Bjørkhaug L; Njølstad PR; Gloyn AL
    Am J Hum Genet; 2020 Oct; 107(4):670-682. PubMed ID: 32910913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel insights into genetics and clinics of the HNF1A-MODY.
    Valkovicova T; Skopkova M; Stanik J; Gasperikova D
    Endocr Regul; 2019 Apr; 53(2):110-134. PubMed ID: 31517624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization and re-interpretation of
    Kavitha B; Ranganathan S; Gopi S; Vetrivel U; Hemavathy N; Mohan V; Radha V
    Front Endocrinol (Lausanne); 2023; 14():1177268. PubMed ID: 37396188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.
    Besser RE; Shepherd MH; McDonald TJ; Shields BM; Knight BA; Ellard S; Hattersley AT
    Diabetes Care; 2011 Feb; 34(2):286-91. PubMed ID: 21270186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HNF1A mutant Ala180Val: Clinical challenges in determining causality of a rare HNF1A variant in familial diabetes.
    Sagen JV; Bjørkhaug L; Haukanes BI; Grevle L; Molnes J; Nedrebø BG; Søvik O; Njølstad PR; Johansson S; Molven A
    Diabetes Res Clin Pract; 2017 Nov; 133():142-149. PubMed ID: 28934671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maturity onset diabetes of the young due to
    Pavić T; Juszczak A; Pape Medvidović E; Burrows C; Šekerija M; Bennett AJ; Ćuća Knežević J; Gloyn AL; Lauc G; McCarthy MI; Gornik O; Owen KR
    Biochem Med (Zagreb); 2018 Jun; 28(2):020703. PubMed ID: 29666556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the promoter regions of disease-causing genes in maturity-onset diabetes of the young patients.
    Komazec J; Ristivojevic B; Zukic B; Zdravkovic V; Karan-Djurasevic T; Pavlovic S; Ugrin M
    Mol Biol Rep; 2020 Sep; 47(9):6759-6768. PubMed ID: 32860162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alternative approach using hs-CRP levels and age of onset in diagnostics of HNF1A-MODY.
    Kickova T; Skopkova M; Dobiasova Z; Lackova G; Belicova Z; Schenkova K; Stanik J; Gasperikova D
    Diabet Med; 2024 May; 41(5):e15265. PubMed ID: 38093550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and characterization of mutations in genes in a large cohort of patients referred to MODY registry.
    Breidbart E; Deng L; Lanzano P; Fan X; Guo J; Leibel RL; LeDuc CA; Chung WK
    J Pediatr Endocrinol Metab; 2021 May; 34(5):633-638. PubMed ID: 33852230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic testing for maturity-onset diabetes of the young resulting in an upgraded genetic classification of an HNF1A gene variant: a case report.
    Pollack-Schreiber N; Nwosu BU; Salemi P
    Front Endocrinol (Lausanne); 2023; 14():1173471. PubMed ID: 37396173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver adenomatosis in patients with hepatocyte nuclear factor-1 alpha maturity onset diabetes of the young (HNF1A-MODY): Clinical, radiological and pathological characteristics in a French series.
    Haddouche A; Bellanne-Chantelot C; Rod A; Fournier L; Chiche L; Gautier JF; Timsit J; Laboureau S; Chaillous L; Valero R; Larger E; Jeandidier N; Wilhelm JM; Popelier M; Guillausseau PJ; Thivolet C; Lecomte P; Benhamou PY; Reznik Y
    J Diabetes; 2020 Jan; 12(1):48-57. PubMed ID: 31166087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in HNF1A result in marked alterations of plasma glycan profile.
    Thanabalasingham G; Huffman JE; Kattla JJ; Novokmet M; Rudan I; Gloyn AL; Hayward C; Adamczyk B; Reynolds RM; Muzinic A; Hassanali N; Pucic M; Bennett AJ; Essafi A; Polasek O; Mughal SA; Redzic I; Primorac D; Zgaga L; Kolcic I; Hansen T; Gasperikova D; Tjora E; Strachan MW; Nielsen T; Stanik J; Klimes I; Pedersen OB; Njølstad PR; Wild SH; Gyllensten U; Gornik O; Wilson JF; Hastie ND; Campbell H; McCarthy MI; Rudd PM; Owen KR; Lauc G; Wright AF
    Diabetes; 2013 Apr; 62(4):1329-37. PubMed ID: 23274891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced pancreatic volume in hepatocyte nuclear factor 1A-maturity-onset diabetes of the young.
    Vesterhus M; Haldorsen IS; Raeder H; Molven A; Njølstad PR
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3505-9. PubMed ID: 18593771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of HNF4A gene variants identify promoter and cell line specific transactivation effects.
    Kaci A; Solheim MH; Silgjerd T; Hjaltadottir J; Hornnes LH; Molnes J; Madsen A; Sjøholt G; Bellanné-Chantelot C; Caswell R; Sagen JV; Njølstad PR; Aukrust I; Bjørkhaug L
    Hum Mol Genet; 2024 May; 33(10):894-904. PubMed ID: 38433330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel variants in the hepatocyte nuclear factor-1alpha gene in South Indian patients with maturity onset diabetes of young.
    Radha V; Ek J; Anuradha S; Hansen T; Pedersen O; Mohan V
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1959-65. PubMed ID: 19336507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HNF1A gene p.I27L is associated with early-onset, maturity-onset diabetes of the young-like diabetes in Turkey.
    Beysel S; Eyerci N; Pinarli FA; Kizilgul M; Ozcelik O; Caliskan M; Cakal E
    BMC Endocr Disord; 2019 May; 19(1):51. PubMed ID: 31109344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
    Kyithar MP; Bacon S; Pannu KK; Rizvi SR; Colclough K; Ellard S; Byrne MM
    Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.